Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Checkpoint Therapeutics Inc (CKPT)

Checkpoint Therapeutics Inc (CKPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses FinancialNewsMedia - Fri Dec 20, 1:12PM CST

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
PSNL : 5.75 (+9.32%)
ONC.TO : 1.19 (-9.16%)
TEM : 35.54 (+7.60%)
CRDF : 4.26 (-5.12%)
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses Newswire.ca - Fri Dec 20, 11:52AM CST

/CNW/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights, underscoring major...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
PSNL : 5.75 (+9.32%)
ONC.TO : 1.19 (-9.16%)
TEM : 35.54 (+7.60%)
CRDF : 4.26 (-5.12%)
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments Newswire.ca - Wed Dec 18, 10:12AM CST

/CNW/ -- USA News Group News Commentary – The American Cancer Society recently released its Advances in Oncology – 2024 Research Highlights report that...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
LLY : 767.76 (+1.35%)
ONC.TO : 1.19 (-9.16%)
OSTX : 3.97 (+1.53%)
CRDF : 4.26 (-5.12%)
FDA Approves Checkpoint Therapeutics' UNLOXCYT™ for Advanced Cutaneous Squamous Cell Carcinoma Quiver Quantitative, Inc. - Sat Dec 14, 3:32AM CST

Checkpoint Therapeutics announces FDA approval of UNLOXCYT™ for treating advanced cutaneous squamous cell carcinoma in non-surgical patients.Quiver AI SummaryCheckpoint Therapeutics, Inc. announced that...

CKPT : 3.75 (+11.28%)
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) GlobeNewswire - Fri Dec 13, 5:15PM CST

FBIO : 1.7200 (-1.15%)
CKPT : 3.75 (+11.28%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend Newswire.ca - Mon Dec 2, 9:18AM CST

/CNW/ -- USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among people under...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
RCUS : 15.50 (+0.26%)
BCTX : 0.5610 (-4.12%)
ONC.TO : 1.19 (-9.16%)
AKYA : 2.49 (-2.35%)
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend BayStreet.ca - Mon Dec 2, 7:58AM CST

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is...

ONCY : 0.8310 (-6.36%)
CKPT : 3.75 (+11.28%)
RCUS : 15.50 (+0.26%)
BCTX : 0.5610 (-4.12%)
AKYA : 2.49 (-2.35%)
ONC.TO : 1.19 (-9.16%)
Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates GlobeNewswire - Tue Nov 12, 3:30PM CST

FBIO : 1.7200 (-1.15%)
CKPT : 3.75 (+11.28%)
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week Stocktwits - Mon Nov 11, 2:32AM CST

As the new week unfolds, earnings and economic data will again dictate sentiment.

MARA : 19.96 (-2.01%)
BLK : 1,028.69 (+1.22%)
NFLX : 909.05 (+0.78%)
PDD : 99.51 (-1.48%)
AUPH : 9.03 (-0.11%)
CKPT : 3.75 (+11.28%)
EVH : 11.41 (+2.06%)
EBS : 8.10 (+0.50%)
BIDU : 85.80 (+0.26%)
SPY : 591.15 (+1.20%)
COIN : 278.71 (+1.75%)
Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma Globe Newswire - Thu Jun 16, 2022

Objective response rate of 54.8% in patients with locally advanced cSCC, a potential 2nd indication for cosibelimabPreviously met primary endpoint in...

CKPT : 3.75 (+11.28%)

Barchart Exclusives

3 Highly-Rated Dividend Stocks To Buy on the Dip Barchart - Fri Dec 20, 6:00PM CST
Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot